Skip to main content

Table 1 Clinical and epidemiological characteristics of HCV-infected patients

From: CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study

Characteristics Data
No. 389
Male sex 228 (58.6%)
Age (years) 49.6 (43.2; 57.7)
Time of HCV diagnosis (years) 8.6 (2.1; 14.1)
High alcohol intake 75 (19.3%)
Prior injection drug use 66 (17%)
HCV genotype (n = 383)
 1 311 (81.2%)
 2 5 (1.3%)
 3 42 (11%)
 4 23 (6%)
 5 2 (0.5%)
Non-responder (peg-IFN-α/RBV) 81 (20.8%)
Liver stiffness (kPa) 6.9 (5.5; 10.5)
 F0–F1 (<7.1) 205 (52.7%)
 F2 (7.1–9.4) 65 (16.7%)
 F3 (9.5–12.4) 48 (12.3%)
 F4.1 (12.5–21.4) 41 (10.5%)
 F4.2 (≥21.5) 30 (7.7%)
  1. Values expressed as absolute numbers (%) and median (percentile 25; percentile 75)
  2. HCV hepatitis C virus, LSM liver stiffness measure, kPa kilopascal, IFN interferon, peg-IFN-α/RBV pegilated-interferon-alpha/ribavirin